[1]
|
Czaja, A.J. (2019) Examining Pathogenic Concepts of Autoimmune Hepatitis for Cues to Future Investigations and In-terventions. World Journal of Gastroenterology, 25, 6579-6606. https://doi.org/10.3748/wjg.v25.i45.6579
|
[2]
|
闫惠平, 刘燕敏, 张海萍. 近二十年我国自身免疫性肝病领域发展历程的回顾与展望[J]. 临床肝胆病杂志, 2022, 38(4): 737-742.
|
[3]
|
王聪, 吴雄健, 黄才斌. 自身免疫性肝病的发病机制及诊疗进展[J]. 中外医疗, 2021, 40(30): 194-198.
|
[4]
|
Capra, A.P., Chiara, E. and Briuglia, S. (2021) Autoimmune Hepatitis in Genetic Syndromes: A Litera-ture Review. World Journal of Hepatology, 13, 1328-1340. https://doi.org/10.4254/wjh.v13.i10.1328
|
[5]
|
Czaja, A.J. (2016) Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions. Gut and Liver, 10, 177-203. https://doi.org/10.5009/gnl15352
|
[6]
|
马雄, 王绮夏, 肖潇, 等. 自身免疫性肝炎诊断和治疗指南(2021) [J]. 临床肝胆病杂志, 2022(1): 1-8.
|
[7]
|
Tanaka, A., Mori, M., Matsumoto, K., et al. (2019) Increase Trend in the Prevalence and Male-to-Female Ratio of Primary Biliary Cholangitis, Autoimmune Hepatitis, and Primary Sclerosing Cholangitis in Japan. Hepatology Research, 49, 881-889. https://doi.org/10.1111/hepr.13342
|
[8]
|
Mack, C.L., Adams, D., Assis, D.N., et al. (2020) Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines from the American Association for the Study of Liver Diseases. Hepatology, 72, 671-722. https://doi.org/10.1002/hep.31065
|
[9]
|
Liberal, R., Grant, C.R., Mieli-Vergani, G., et al. (2013) Auto-immune Hepatitis: A Comprehensive Review. Journal of Autoimmunity, 41, 126-139. https://doi.org/10.1016/j.jaut.2012.11.002
|
[10]
|
Li, Y., Yan, L., Wang, R., et al. (2022) Serum Immunoglobulin G Levels Predict Biochemical and Histological Remission of Autoimmune Hepatitis Type 1: A Single-Center Experience and Literature Review. Clinical Reviews in Allergy & Immunology, 62, 292-300. https://doi.org/10.1007/s12016-021-08833-w
|
[11]
|
Sebode, M., Weiler-Normann, C., Liwinski, T., et al. (2018) Autoantibodies in Autoimmune Liver Disease-Clinical and Diagnostic Relevance. Frontiers in Immunology, 9, Article No. 609. https://doi.org/10.3389/fimmu.2018.00609
|
[12]
|
Sucher, E., Sucher, R., Gradistanac, T., et al. (2019) Au-toimmune Hepatitis-Immunologically Triggered Liver Pathogenesis-Diagnostic and Therapeutic Strategies. Journal of Immunology Research, 2019, Article ID: 9437043.
https://doi.org/10.1155/2019/9437043
|
[13]
|
Liwinski, T. and Schramm, C. (2017) Autoimmune Hepatitis-Update on Clinical Management in 2017. Clinics and Research in Hepatology and Gastroenterology, 41, 617-625. https://doi.org/10.1016/j.clinre.2017.07.002
|
[14]
|
王玲, 朱文静. 自身抗体检测对自身免疫性肝炎的临床诊断价值[J]. 临床医学研究与实践, 2022, 7(9): 123-126.
|
[15]
|
Czaja, A.J. (2011) Performance Parameters of the Conven-tional Serological Markers for Autoimmune Hepatitis. Digestive Diseases and Sciences, 56, 545-554. https://doi.org/10.1007/s10620-010-1501-1
|
[16]
|
Toh, B.H. (2017) Diagnostic Autoantibodies for Autoimmune Liver Diseases. Clinical & Translational Immunology, 6, e139. https://doi.org/10.1038/cti.2017.14
|
[17]
|
何亚男, 郑长清. 血清自身抗体检测对自身免疫性肝病的研究进展[J]. 胃肠病学和肝病学杂志, 2020, 29(1): 104-107.
|
[18]
|
韩莹, 闫惠平, 廖慧钰, 等. 抗肝肾微粒体抗体在肝病患者中的临床意义评价[J]. 中华肝脏病杂志, 2017, 25(11): 852-857.
|
[19]
|
Martini, E., Abuaf, N., Cavalli, F., et al. (1988) Antibody to Liver Cytosol (Anti-LC1) in Patients with Autoimmune Chronic Active Hepatitis Type 2. Hepatology, 8, 1662-1666. https://doi.org/10.1002/hep.1840080632
|
[20]
|
Hennes, E.M., Zeniya, M., Czaja, A.J., et al. (2008) Simplified Crite-ria for the Diagnosis of Autoimmune Hepatitis. Hepatology, 48, 169-176. https://doi.org/10.1002/hep.22322
|
[21]
|
Washington, M.K. (2007) Autoimmune Liver Disease: Overlap and Outli-ers. Modern Pathology, 20, S15-S30.
https://doi.org/10.1038/modpathol.3800684
|
[22]
|
Gleeson, D. and Heneghan, M.A. (2011) British Society of Gas-troenterology (BSG) Guidelines for Management of Autoimmune Hepatitis. Gut, 60, 1611-1629. https://doi.org/10.1136/gut.2010.235259
|
[23]
|
苗琪, 陈晓宇. 自身免疫性肝炎的肝组织病理学诊断[J]. 临床肝胆病杂志, 2020, 36(4): 728-730.
|
[24]
|
卞兆连, 秦刚, 陈琳, 等. 穿入现象在自身免疫性肝炎中的临床意义[J]. 肝脏, 2016, 21(9): 729-732.
|
[25]
|
Sarcognato, S., Sacchi, D., Grillo, F., et al. (2021) Autoimmune Biliary Diseases: Pri-mary Biliary Cholangitis and Primary Sclerosing Cholangitis. Pathologica, 113, 170-184. https://doi.org/10.32074/1591-951X-245
|
[26]
|
Zeng, N., Duan, W., Chen, S., et al. (2019) Epidemiology and Clin-ical Course of Primary Biliary Cholangitis in the Asia-Pacific Region: A Systematic Review and Meta-Analysis. Hepa-tology International, 13, 788-799.
https://doi.org/10.1007/s12072-019-09984-x
|
[27]
|
Chalifoux, S.L., Konyn, P.G., Choi, G., et al. (2017) Extrahe-patic Manifestations of Primary Biliary Cholangitis. Gut and Liver, 11, 771-780. https://doi.org/10.5009/gnl16365
|
[28]
|
中华医学会肝病学分会. 原发性胆汁性胆管炎的诊断和治疗指南(2021) [J]. 中华肝脏病杂志, 2022, 30(3): 264-275.
|
[29]
|
Joshi, S., Cauch-Dudek, K., Heathcote, E.J., et al. (2002) Antimito-chondrial Antibody Profiles: Are They Valid Prognostic Indicators in Primary Biliary Cirrhosis? American Journal of Gastroenterology, 97, 999-1002.
https://doi.org/10.1111/j.1572-0241.2002.05620.x
|
[30]
|
Granito, A., Muratori, P., Quarneti, C., et al. (2012) Anti-nuclear Antibodies as Ancillary Markers in Primary Biliary Cirrhosis. Expert Review of Molecular Diagnostics, 12, 65-74. https://doi.org/10.1586/erm.11.82
|
[31]
|
Nakamura, M., Kondo, H., Mori, T., et al. (2007) Anti-gp210 and Anti-Centromere Antibodies Are Different Risk Factors for the Progression of Primary Biliary Cirrhosis. Hepatology, 45, 118-127. https://doi.org/10.1002/hep.21472
|
[32]
|
Liu, H., Norman, G.L., Shums, Z., et al. (2010) PBC Screen: An IgG/IgA Dual Isotype ELISA Detecting Multiple Mitochondrial and Nuclear Autoantibodies Specific for Primary Biliary Cirrhosis. Journal of Autoimmunity, 35, 436-442.
https://doi.org/10.1016/j.jaut.2010.09.005
|
[33]
|
Murillo Perez, C.F., Hirschfield, G.M., Corpechot, C., et al. (2019) Fibrosis Stage Is an Independent Predictor of Outcome in Primary Biliary Cholangitis despite Biochemical Treatment Response. Alimentary Pharmacology & Therapeutics, 50, 1127-1136. https://doi.org/10.1111/apt.15533
|
[34]
|
Tanaka, A. (2021) Current Understanding of Primary Biliary Cholangitis. Clinical and Molecular Hepatology, 27, 1-21.
https://doi.org/10.3350/cmh.2020.0028
|
[35]
|
Scheuer, P. (1967) Primary Biliary Cirrhosis. Proceedings of the Royal Society of Medicine, 60, 1257-1260.
https://doi.org/10.1177/003591576706001205
|
[36]
|
Ludwig, J., Dickson, E.R. and McDonald, G.S. (1978) Staging of Chronic Nonsuppurative Destructive Cholangitis (Syndrome of Primary Biliary Cirrhosis). Virchows Archiv A, Pathological Anatomy and Histology, 379, 103-112.
https://doi.org/10.1007/BF00432479
|
[37]
|
宋欣航, 于涓翰, 程肇平, 等. 原发性胆汁性胆管炎的病理学分期系统[J]. 临床肝胆病杂志, 2022, 38(3): 653-655.
|
[38]
|
Nakanuma, Y., Zen, Y., Harada, K., et al. (2010) Application of a New Histological Staging and Grading System for Primary Biliary Cirrhosis to Liver Biopsy Specimens: Interob-server Agreement. Pathology International, 60, 167-174.
https://doi.org/10.1111/j.1440-1827.2009.02500.x
|